Amicus Therapeutics (FOLD) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $12.9 million.
- Amicus Therapeutics' Other Non-Current Assets fell 3095.09% to $12.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.9 million, marking a year-over-year decrease of 3095.09%. This contributed to the annual value of $13.6 million for FY2024, which is 2647.55% down from last year.
- As of Q3 2025, Amicus Therapeutics' Other Non-Current Assets stood at $12.9 million, which was down 3095.09% from $13.4 million recorded in Q2 2025.
- Amicus Therapeutics' Other Non-Current Assets' 5-year high stood at $25.2 million during Q1 2022, with a 5-year trough of $12.9 million in Q3 2025.
- In the last 5 years, Amicus Therapeutics' Other Non-Current Assets had a median value of $18.7 million in 2024 and averaged $18.7 million.
- As far as peak fluctuations go, Amicus Therapeutics' Other Non-Current Assets skyrocketed by 2792.35% in 2021, and later tumbled by 3095.09% in 2025.
- Over the past 5 years, Amicus Therapeutics' Other Non-Current Assets (Quarter) stood at $24.4 million in 2021, then fell by 21.23% to $19.2 million in 2022, then fell by 3.58% to $18.6 million in 2023, then dropped by 26.48% to $13.6 million in 2024, then dropped by 5.45% to $12.9 million in 2025.
- Its Other Non-Current Assets stands at $12.9 million for Q3 2025, versus $13.4 million for Q2 2025 and $14.0 million for Q1 2025.